Analyst firms · Leerink Partners · ALVR
Leerink Partners ALVR price target and rating history
AlloVir Inc. (ALVR) · Health Care
Leerink Partners rates AlloVir Inc. (ALVR) Market Perform with a $30 price target, as of its latest action on Dec 22, 2023. It has published 4 rating actions on ALVR since November 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Market Perform
- Price target
- $30
- Median target, all firms
- Too few
- Actions on ALVR
- 4
Leerink Partners price target on ALVR
Every Leerink Partners rating on ALVR
- Dec 22, 2023
- Feb 10, 2022
- Dec 17, 2021
- Nov 8, 2021
Questions about Leerink Partners and ALVR
- What is Leerink Partners's price target for ALVR?
- Leerink Partners's latest stated price target for AlloVir Inc. (ALVR) is $30, from its action on Feb 10, 2022.
- What is Leerink Partners's rating on ALVR?
- Leerink Partners rates ALVR Market Perform, a neutral rating, as of Dec 22, 2023.
- When did Leerink Partners last change its view on ALVR?
- On Dec 22, 2023, Leerink Partners downgrades to Market Perform from Outperform.
More ALVR rating histories
All Leerink Partners ratingsALVR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.